Mammalian Expression Systems Leading with Over 40% Share
Among the various expression systems, the adoption of mammalian expression systems is expected to remain prominent over the next decade. Preferred for their high-yield protein quotient as well as immense utilization in antibody production, and protein structural analysis, mammalian expression systems continue to capture a relatively higher market share.
Accounting for nearly one-third share of total revenue, prokaryotic expression systems are also seeing healthy adoption, owing to low-cost culture and flexibility. Meanwhile, the adoption of other expression systems such as insect cell and yeast expression systems would increase at a steady pace.
Market Consolidation Predominant in Developed Regions
At present, North America and Western Europe are leaders in the global protein expression technology market, with the market in the former representing the most worthwhile growth opportunities. Presence of well-established biotechnology infrastructure and conducive regulatory environment are the key factors triggering the adoption of protein expression technology in these developed regions.
On the back of rising usage of biotechnology and genetic engineering in the medical science and pharmaceutical industry, the protein expression technology market is also receiving strong impetus from Asia Pacific (APAC).
Greater Emphasis on Producing High Quality Reagents
Although the protein expression technology market is highly fragmented, consisting of market leaders and followers, there are a few firms that are solely focused on delivering reagents for research & diagnostic purposes. Moreover, most of the leading companies combine research products and reagents with in-vitro diagnostics tools and other equipment.
Keeping strong focus on providing reagents ensures high-quality products, customer retention, and a stable supply chain. As investments in the development molecular biology enzymes, kits, and reagents are likely to ascend in the near future, players in the protein expression technology market must tap this potential opportunity for stable returns.
How Growth will Unfold
Reagents including oligomers and antibodies remain the preferable choice in protein expression technology for a desired transformation of an organic substance. In terms of growth rate as well as revenue generation, reagents will maintain their primacy in the global protein expression technology market throughout the period of projection.
By 2023, the supply of reagents is expected to surpass the US$ 1 Bn mark. Expression vectors and competent cells are also witnessing promising demand growth, holding a collective share of over 40%.
FREQUENTLY ASKED QUESTIONS ABOUT PROTEIN EXPRESSION TECHNOLOGY MARKET
What is the status of the global protein expression technology market?
The global protein expression technology market is poised for a healthy CAGR over the period of forecast (2019 - 2029). Towards the end of the year 2025, the protein expression technology market is most likely to surpass the US$ 3 Bn mark.
Who are the leading players in the protein expression technology market?
Some of the leading players operating in the global protein expression technology market are:
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Bio-Rad Laboratories Inc.
- Lonza AG
Why are protein expression technology market players focusing more on North America and Western Europe?
Owing to increasing per capita healthcare expenditure, favorable reimbursement policies, and strong establishment of biotechnology infrastructure, protein expression technology market players are eyeing North America and Western Europe for increased sales and bigger margins.
What is driving the protein expression technology market?
Rising adoption of biotechnology and genetic engineering in the medical science and pharmaceuticals industry is currently driving the growth of the protein expression technology market. High success rate of therapeutic products and recombinant DNA technology are projected to boost the popularity of protein expression technology in the near future.
Which application area is expected to be the most lucrative?
According to FMI, players in the global protein expression technology market will continue to target protein therapeutics for lucrative returns during the forecast period of 2019-2029, followed by drug discovery, protein purification, and disease diagnostic & monitoring.
PROTEIN EXPRESSION TECHNOLOGY MARKET TAXONOMY
The global protein expression technology is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to readers.
Expression System
- Insect Cell Expression Systems
- Prokaryotic Expression Systems
- Mammalian Cells Expression Systems
- Yeast Expression Systems
- Other Expression Systems
Product Type
- Expression Vectors
- Reagents
- Competent Cells
- Instruments
Application
- Drug Discovery
- Protein Purification
- Protein Therapeutics
- Disease Diagnostics and Monitoring
End User
- Biotechnological Companies
- Pharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Japan
- Middle East and Africa
Need specific information?
In the news
by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights
Our Clients
View Our Reports from Healthcare
View Reports